Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-01-01Clinical Trial Update: Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial) [Phase 3]
Phase 3 study evaluating two fixed doses of OPC-34712 as adjunctive therapy for adults with major depressive disorder has completed. Results…
-
CLINICAL_TRIALS research · 2015-12-31Clinical Trial Update: Pharmacogenetic Study of Mirtazapine Response in Depressed Patients [NA]
An update on a pharmacogenetic study evaluating genetic factors that influence response to mirtazapine in patients with depression.
-
CLINICAL_TRIALS research · 2015-12-31Clinical Trial Update: Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic Phenotype [NA]
Clinical trial update on predicting antidepressant response in depression using pharmacogenetics and peripheral lymphocytic phenotype, spons…
-
CLINICAL_TRIALS research · 2015-12-31Clinical Trial Update: Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients [NA]
This clinical trial update describes a pharmacogenomic study aiming to predict antidepressant responsiveness in patients with depression, sp…
-
CLINICAL_TRIALS research · 2015-12-31Clinical Trial Update: Predict Antidepressant Responsiveness Using Pharmacogenomics [NA]
Clinical trial update on predicting antidepressant responsiveness using pharmacogenomics, sponsored by Samsung Medical Center. The study inv…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-12-31Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation(rTMS) in the Treatment of Depression
This document provides an update on a clinical trial evaluating repetitive transcranial magnetic stimulation (rTMS) for the treatment of Maj…
-
CLINICAL_TRIALS research · 2015-12-31Clinical Trial Update: Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning [NA]
A clinical trial update describing the development of an escitalopram genomic device using candidate gene and genome-wide approaches; the cu…
-
CLINICAL_TRIALS research · 2015-12-31Clinical Trial Update: Development of A Technique to Predict Antidepressant Responsiveness in Depressive Patients [NA]
A trial update about a technique to predict antidepressant response in patients with major depressive disorder; the current status is unknow…
-
CLINICAL_TRIALS research · 2015-12-31Clinical Trial Update: Effects of Antidepressant on Postsynaptic Signal Transduction in Serotonergic System of Depressed Patients [NA]
Clinical trial exploring the effects of an antidepressant on postsynaptic signal transduction in the serotonergic system of patients with ma…
-
CLINICAL_TRIALS research · 2015-12-31Clinical Trial Update: Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness [NA]
This document reports a clinical trial update on developing a pharmacogenomic method to predict antidepressant responsiveness in depression.…
-
CLINICAL_TRIALS research · 2015-12-31Clinical Trial Update: Making Decisions About Depression Medications [NA]
Clinical trial evaluating how patients and clinicians decide which medications to use for depression has completed. The study status is list…
-
FDA approval · 2015-12-30FDA Approved: REMERON — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for REMERON (mirtazapine) submitted by Organon LLC.
-
FDA label_change · 2015-12-30FDA Approved: REMERONSOLTAB — Supplemental Application (Organon LLC)
FDA approved a supplemental application for REMERON SolTab (mirtazapine) from Organon LLC, resulting in a labeling change.
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Trazodone Once a Day in Major Depression Disorder [Phase 3]
A Phase 3 trial evaluating once-daily trazodone for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-29Clinical Trial Update: Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Subjects Exhibiting Neuropsychiatric Disorders [NA]
A completed clinical study assessing patient outcomes after pharmacogenetic testing in subjects with depression or anxiety disorders, sponso…
-
FDA approval · 2015-12-23FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for sertraline hydrochloride (Lupin Pharmaceuticals, Inc.), a generic product under an ANDA.
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood Levels [Phase 1]
A Phase 1 clinical trial evaluated whether gastric bypass surgery affects blood levels of the antidepressant venlafaxine ER.
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Treatment-Resistant Depression Registry
Clinical trial NCT00320372, a treatment-resistant depression registry sponsored by Cyberonics, Inc., is reported as completed with results p…
-
FDA approval · 2015-12-22FDA Approved: DULOXETINE DELAYED-RELEASE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
The FDA approved Breckenridge Pharmaceutical's supplemental application for a duloxetine hydrochloride delayed-release product, granting app…
-
CLINICAL_TRIALS withdrawal · 2015-12-21Clinical Trial Update: Exercise Training in Depressed Traumatic Brain Injury Survivors [NA]
A clinical trial examining exercise training for individuals with depression following traumatic brain injury was withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Coping With Adolescent Peer Victimization and Reducing Anxious/Depressed Symptoms [Phase 2]
Phase 2 trial sponsored by the University of Miami evaluating a coping-with-peer-victimization intervention to reduce anxious and depressed …
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Incomplete Response in Late Life Depression: Getting to Remission (IRL GREY) [Phase 4]
This Phase 4 clinical trial update reports results from the IRL GREY study on incomplete responders with late-life depression aiming for rem…
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Cognitive Control Training for Remitted Depressed Patients [NA]
The clinical trial evaluating cognitive control training for individuals with major depressive disorder in remission has completed.
-
FDA label_change · 2015-12-16FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Viibryd (vilazodone hydrochloride) from Allergan, Inc., indicating changes to the product labeli…
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients [Phase 4]
Phase 4 study investigating the effects of olanzapine on sleep architecture and related cognitive changes in patients with bipolar disorder …